MAN ON FIRE--! NAILING EVERY SINGLE EARNINGS PLAY ->>> UNHEARD OF!!!! Workday price target raised by $20 at Stifel, here's why » 06:57 WDAY Workday price target raised by $30 at Canaccord,»Workday price target raised by $45 at BofA, » 06:17 WDAY BofA raised the… Workday price target raised by $15 at DA Davidson, » 05:08 WDAY DA Davidson raised the…Workday price target raised by $10 at Deutsche Bank, here's why » 04:32 WDAY Deutsche Bank raised the… Yesterday--- THEY LIKE IT! YOU LIKE IT!!! DO YOU LIKE IT???? DO YOU WANT MORE~~~~~~~~~~~~~~~~~~~
Unusual Machines reports over 6,700 Rotor Riot Brave F7 controllers ordered » 07:07 UMAC UMAC Unusual Machines, Inc.---Possible gummy-! $1.77-0.03(-1.67%)4:00 PM 08/22/24 NYSE |$USD |Pre-Market:$2.05+0.28(+15.82%)7:06 AM Company Profile Unusual Machines, Inc. designs, manufactures, and sells ultra-low latency video goggles for drone pilots. It operates a drone-focused e-commerce marketplace. The company serves drone pilots, hobbyists, and recreational services. The company was formerly known as AerocarveUS Corporation and changed its name to Unusual Machines, Inc. in July 2022. Unusual Machines, Inc. was incorporated in 2019 and is based in Orlando, Florida.
What does this even mean? We want a "Buy for earnings" statement, not an outloud musing over what might happen. Looks like we can't can't get in at $207. Your buy idea.
I bought! I told you to buy!I told you how to buy. You were babbling about nothing and missed out again./// I gave it out no less than three times at the end of the day... Go do a search if you want you missed it! Rolling with the best bro~~~~~~~~~~~
BNTX BioNTech SE $87.23-1.76(-1.98%)4:00 PM 08/22/24 NASDAQ |$USD |Pre-Market:$87.62+0.39(+0.45%)7:01 AM This is really important for science. You may not know this but people around the world are starting to get ling cancer without having ever smoked. This is a serious warning to mankind about pollution and particles in the air. We have to pray this gene splicing works. Exclusive Lung cancer patient is first in UK to receive experimental vaccine The vaccine is made by BioNTech using the same mRNA technology that underpinned its highly effective COVID jab. Janusz Racz, 67, had six syringes of the jab, each containing genetic material for a different part of the tumour, to train five billion cells in his immune system to go on the attack. About 130 patients with non-small cell lung cancer will take part in the study, with six hospitals in the UK involved. "If I was the hundredth or the first [study volunteer] it does not matter for me," Mr Racz said. "I believe it will help me - and help other people if the vaccine goes to production faster. "COVID vaccines helped millions of people. This will also help millions of people."